| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.11.25 | Roche, Manifold Bio Sign $2B Deal to Develop Next-Gen Brain Shuttles | ||
| 03.11.25 | Ardena Appoints Chief Quality Officer and Chief Information Officer | ||
| 31.10.25 | Ajinomoto, Astellas Enter ADC Technology Agreement | ||
| 31.10.25 | Lilly to Invest $1.2B to Expand Puerto Rico Manufacturing Site | ||
| 30.10.25 | Debiopharm, NetTargets Partner to Advance Next-Gen ADCs | ||
| 30.10.25 | Cryoport Systems Secures ISO Certification for Cell Therapy Transport Standards | ||
| 30.10.25 | Cellectricon Launches Neurotoxicity Testing Services | ||
| 30.10.25 | Apeloa Pharmaceutical Passes 20th FDA Inspection | ||
| 30.10.25 | AbolerIS Pharma Appoints Philippe Alen Chief Business Officer | ||
| 30.10.25 | Piramal Partners with IntoCell to Explore Opportunities in ADC Development | ||
| 30.10.25 | The Pistoia Alliance Launches Phase 3 of CMC Process Ontology Project | ||
| 29.10.25 | Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product | ||
| 29.10.25 | SK pharmteco, Lotte Biologics Partner to Strengthen Global ADC CDMO Capabilities | ||
| 29.10.25 | Thermo Fisher to Acquire Clario for $8.875 Billion | ||
| 29.10.25 | Wheeler Bio Partners with Mitsubishi to Expand Asia Pacific Business Development | ||
| 29.10.25 | 10x Genomics Launches New Chromium Flex for Single-Cell Research | ||
| 28.10.25 | Symbiosis Strengthens Business Development Team in the U.S. | ||
| 28.10.25 | Lifecore, PolyPeptide Partner on Peptide Manufacturing for U.S. Market | ||
| 28.10.25 | Catalent Unveils New Brand Amid Strategic Shift and Global Expansion | ||
| 28.10.25 | BioCina Names Dr. Thomas Broudy as CEO | ||
| 28.10.25 | Slingshot Biosciences, Cellares Partner on Cell Therapy Manufacturing | ||
| 28.10.25 | Kemwell's Bengaluru Facility Completes U.S. FDA Inspection | ||
| 28.10.25 | Lupin Inaugurates New Headquarters in Bridgewater, NJ | ||
| 28.10.25 | Aji Bio-Pharma, Olon Partner to Deliver Drug Substance Manufacturing Services | ||
| 28.10.25 | Bora Pharmaceuticals to Scale Supply of Oncology Therapy |